4.6 Article

Adherence to antipsychotic laboratory monitoring guidelines in children and youth: a population-based study

Related references

Note: Only part of the references are listed.
Article Health Policy & Services

Cardiometabolic Monitoring and Sociodemographic and Clinical Characteristics of Youths Prescribed Antipsychotic Medications

Loretta Hsueh et al.

Summary: This study examines the time trends and patient characteristics related to guideline-recommended cardiometabolic risk factor monitoring among youths treated with antipsychotic medications. The findings indicate that although there has been a modest increase in cardiometabolic monitoring over time, a significant proportion of youths still do not receive proper monitoring.

PSYCHIATRIC SERVICES (2023)

Article Pediatrics

Impact of Antipsychotic Guidelines on Laboratory Monitoring in Children with Neurodevelopmental Disorders

Imaan Kara et al.

Summary: The study found that SGA monitoring rates did not significantly improve after the publication of the CAMESA guidelines. There was no significant change in the proportion of patients receiving laboratory monitoring between the two time periods.

JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY (2021)

Article Psychiatry

Long-Term Metabolic Monitoring of Youths Treated with Second-Generation Antipsychotics 5 Years after Publication of the CAMESA Guidelines Are We Making Progress? Surveillance Metabolique a Long Terme des Jeunes Traites par Antipsychotiques de Deuxieme Generation, Cinq ans Apres la publication des Lignes Directrices Camesa: Faisons-Nous des Progres?

Sarra Jazi et al.

Summary: The study found that less than half of patients received metabolic monitoring five years after the publication of the CAMESA guidelines. Factors such as age, diagnostic category, psychiatric comorbidities, medication dose, clinician experience, and concomitant medications influenced monitoring rates.

CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE (2021)

Article Pediatrics

Provider Specialty and Receipt of Metabolic Monitoring for Children Taking Antipsychotics

Elizabeth Shenkman et al.

Summary: This study examined the impact of provider specialty on metabolic monitoring for children taking antipsychotic medication. Shared care arrangements significantly increased the likelihood of metabolic monitoring, highlighting the importance of provider attribution in driving quality improvement efforts.

PEDIATRICS (2021)

Review Pediatrics

Interventions to Improve Metabolic Risk Screening Among Children and Adolescents on Antipsychotic Medication: A Systematic Review

Osnat C. Melamed et al.

Summary: In the context of antipsychotic metabolic screening, some interventions have shown modest improvements, but the studies generally have poor methodological quality, warranting further improvement. Common improvement strategies may impact provider behavior towards conducting metabolic screening.

JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY (2021)

Article Health Policy & Services

Policy and Practice Innovations to Improve Prescribing of Psychoactive Medications for Children

Kelly J. Kelleher et al.

PSYCHIATRIC SERVICES (2020)

Article Pediatrics

The Pharmacoepidemiology of Psychotropic Medication Use in Canadian Children from 2012 to 2016

Tamara Pringsheim et al.

JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY (2019)

Article Medicine, General & Internal

Project ECHO: Building capacity to manage complex conditions in rural, remote and underserved areas

Andrea D. Furlan et al.

CANADIAN JOURNAL OF RURAL MEDICINE (2019)

Article Psychology, Clinical

Family Burden of Raising a Child with ADHD

Xin Zhao et al.

JOURNAL OF ABNORMAL CHILD PSYCHOLOGY (2019)

Article Psychiatry

Temporal Trends in Mental Health Service Utilization across Outpatient and Acute Care Sectors: A Population-Based Study from 2006 to 2014

Maria Chiu et al.

CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE (2018)

Article Health Policy & Services

A Medicaid Quality Improvement Collaborative on Psychotropic Medication Prescribing for Children

Jonathan Thackeray et al.

PSYCHIATRIC SERVICES (2018)

Article Pediatrics

Improving Cardiometabolic Monitoring of Children on Antipsychotics

Robert O. Cotes et al.

JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY (2017)

Article Health Policy & Services

Monitoring of Patients on Second-Generation Antipsychotics: A National Survey of Child Psychiatrists

Jennifer L. McLaren et al.

PSYCHIATRIC SERVICES (2017)

Article Psychology, Clinical

The efficacy of benzodiazepines as acute anxiolytics in children: A meta-analysis

Heide Kuang et al.

DEPRESSION AND ANXIETY (2017)

Article Psychiatry

Family Burden Among Parents of Children With Intellectual Disability

Fatma Dilek Turan Gurhopur et al.

JOURNAL OF PSYCHIATRIC NURSING (2017)

Article Pediatrics

Child and Adolescent Psychiatrists' Reported Monitoring Behaviors for Second-Generation Antipsychotics

Angie Mae Rodday et al.

JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY (2015)

Article Health Policy & Services

Metabolic Monitoring for Youths Initiating Use of Second-Generation Antipsychotics, 2003-2011

John G. Connolly et al.

PSYCHIATRIC SERVICES (2015)

Article Psychology, Developmental

Practice Parameter for the Assessment and Treatment of Children and Adolescents With Schizophrenia

Jon McClellan et al.

JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY (2013)

Article Psychiatry

Antipsychotics and the Risk of Type 2 Diabetes Mellitus in Children and Youth

William V. Bobo et al.

JAMA PSYCHIATRY (2013)

Article

Metabolic Screening in Children Receiving Antipsychotic Drug Treatment

Elaine H. Morrato et al.

ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE (2012)

Article Pharmacology & Pharmacy

Adverse Effects of Second-Generation Antipsychotics in Children and Adolescents A Bayesian Meta-Analysis

David Cohen et al.

JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2012)

Article Behavioral Sciences

A Pilot Study to Improve Venipuncture Compliance in Children and Adolescents with Autism Spectrum Disorders

Caroline J. Davit et al.

JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS (2011)

Article Family Studies

Pediatric mental health problems and associated burden on families

Amy J. Houtrow et al.

VULNERABLE CHILDREN AND YOUTH STUDIES (2011)

Article Medicine, General & Internal

Cardiometabolic Risk of Second-Generation Antipsychotic Medications During First-Time Use in Children and Adolescents

Christoph U. Correll et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)

Article Health Care Sciences & Services

A comparison of two methods for estimating prevalence

Martin R. Petersen et al.

BMC MEDICAL RESEARCH METHODOLOGY (2008)

Review Psychology, Developmental

Psychopharmacological treatment for very young children: Contexts and guidelines

Mary Margaret Gleason et al.

JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY (2007)

Article Health Care Sciences & Services

Mental health disorders in childhood: Assessing the burden on families

Susan H. Busch et al.

HEALTH AFFAIRS (2007)

Review Psychology, Developmental

Practice parameter for the assessment and treatment of children and adolescents with oppositional defiant disorder

[Anonymous]

JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY (2007)

Review Health Care Sciences & Services

A review of uses of health care utilization databases for epidemiologic research on therapeutics

S Schneeweiss et al.

JOURNAL OF CLINICAL EPIDEMIOLOGY (2005)

Article Public, Environmental & Occupational Health

A modified Poisson regression approach to prospective studies with binary data

GY Zou

AMERICAN JOURNAL OF EPIDEMIOLOGY (2004)